Telmisartan 80 mg Tablets

Adult dose

For essential hypertension, the recommended dose is 40 mg of Telmisartan orally once daily, with or without food. In some patients, 20 mg once daily may be sufficient. If necessary, the dosage may be increased to 80 mg once daily. The maximum effect on blood pressure reduction is observed 4 to 8 weeks after starting treatment. For the reduction of cardiovascular disease risk, it is recommended to take 80 mg of this medication orally once daily with water, regardless of meals.

This medication can cause serious harm, especially to the fetus and newborn, during pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. It should not be used in pregnant women, women of childbearing potential, patients with severe liver impairment, hereditary angioedema, and those with specific kidney diseases. Patients who are elderly, have hyperkalemia, liver impairment, cardiovascular disease, or renal artery hypertension should use this medication cautiously and periodically check blood pressure and kidney function. While taking this medication, careful observation is needed as blood pressure may drop excessively or potassium levels may rise. If unusual symptoms such as dizziness, fainting, difficulty breathing, skin rash, or myalgia occur, consult a doctor immediately. Patients with impaired kidney function should particularly monitor serum creatinine and potassium levels frequently, and dosage adjustments may be necessary as needed. Interactions may occur when combined with other antihypertensive medications, so it is essential to inform doctors of any other medications being taken. It is advisable to discontinue this medication 24 hours prior to surgery. It is not recommended for children and adolescents under 18, as safety and efficacy have not been established. Caution should be exercised due to the risk of dizziness or fainting when driving or operating machinery. In case of overdose, symptoms such as hypotension, tachycardia, and dizziness may occur, requiring immediate treatment; this medication is not removed by dialysis. Store this medication where children cannot reach, and ensure it is kept dry.

Serious side effects

Urticaria, severe swelling (including angioedema and laryngeal edema), chest discomfort, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in the mouth/eyes, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities with cough and fever, yellowing of the skin or eyes (jaundice), severe lethargy, sudden and severe headache, lightning headache, seizures, confusion, visual disturbances

Mild side effects

• Upper respiratory tract infection
• pharyngitis
• sinusitis
• urinary tract infection
• cystitis
• anemia
• thrombocytopenia
• eosinophilia
• hypersensitivity
• hyperkalemia

This medication should be stored in a tightly sealed container to prevent air or moisture from entering. Additionally, it is advisable to keep the medication at room temperature, between 1°C and 30°C, avoiding extremes of heat or cold.

Appearance

White oval-shaped tablet

Package unit

30 tablets/box [(10 tablets/Alu-Alu*3)]